Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Dyadic International reported a net loss of $5.4 million for the nine months ended September 30, 2026, compared to $5.8 million in the prior year. The company is undergoing a strategic rebranding to Dyadic Applied BioSolutions, shifting focus from research to commercialized protein production platforms across life sciences and food sectors.
aTyr Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock closed at or above $1.00 per share for 10 consecutive business days. The company had previously been under a deficiency notice since December 2025 and was granted an extension until November 30, 2026, to meet the standard. As of this filing, the company has no outstanding deficiency notices from Nasdaq.
Saga Communications reported a net loss of $7.1 million for the third quarter of 2026, primarily driven by a $9.2 million impairment of intangible assets. Net operating revenue decreased to $26.7 million from $28.2 million in the prior year period, while total assets declined to $183.0 million as of September 30, 2026.
Waterstone Financial, Inc. reported net income of $20.6 million for the nine months ended September 30, 2026, an increase from $18.7 million in the prior year period. The company experienced a decrease in total assets to $2.25 billion, primarily driven by a reduction in loans held for sale and cash equivalents, while net interest income improved due to lower interest expenses on deposits and borrowings.
Spectral Capital Corporation reported a significant revenue increase to $865.9 million for the nine months ended September 30, 2026, compared to $3.1 million in the prior year, primarily driven by business combinations. Despite the revenue growth, the company realized a net loss of $5.4 million for the period due to high cost of revenues and increased operating expenses.
Beta Bionics CFO Stephen Feider Sells $153K of Stock
Stephen Feider, CFO, sold 8,874 shares of Beta Bionics, Inc. at $17.21 a share, worth $153K in total on Nov 11, 2026. Shares held after the trade: 159,378 (-5.3%).
Drilling Tools International CEO Robert Wayne Prejean Buys $17.7K of Stock
Robert Wayne Prejean, CEO, bought 10,000 shares of Drilling Tools International Corp at $1.77 a share, worth $17.7K in total on Nov 12, 2026. Shares held after the trade: 601,076 (+1.7%).
PMGC Holdings Inc. reported a significant revenue increase to $4.52 million for the nine months ended September 30, 2026, compared to $0.29 million in the prior year. However, net loss widened to $10.15 million due to increased operating expenses and interest costs, while the company underwent a series of reverse stock splits totaling 1-for-240.
Drilling Tools International Director Eric C. Neuman Buys $66.3K of Stock
Eric C. Neuman, Director, bought 37,267 shares of Drilling Tools International Corp at $1.78 a share, worth $66.3K in total on Nov 12, 2026. Shares held after the trade: 378,789 (+10.9%).
Mgic Investment VP-CAO Julie K. Sperber Sells $230K of Stock
Julie K. Sperber, VP-CAO, sold 8,265 shares of Mgic Investment Corp at $27.79 a share, worth $230K in total on Nov 12, 2026. Shares held after the trade: 74,572 (-10.0%).
NextCure Insider ADAR1 Capital Management LLC Buys $62.9K of Stock
ADAR1 Capital Management LLC bought 12,333 shares of NextCure, Inc. at $5.10 a share, worth $62.9K in total on Nov 11, 2026. Shares held after the trade: 750,289 (+1.7%).
Waterstone Financial reported Q3 2026 net income of $6.2 million, or $0.36 per diluted share, down from $7.9 million in the prior year quarter. The Community Banking segment achieved record quarterly net interest income of $16.0 million, while the Mortgage Banking segment faced a pre-tax loss of $754,000 due to rising mortgage rates and compressed sales margins.
Term
Q3 2026
“We are pleased with the hard work to reach another strong quarter with increased challenges from rising short-term and long-term treasury rates. The Community Banking segment realized another record quarterly net interest income of $16.0 million, which represented a $1.4 million increase compared to the quarter ended September 30, 2025.”
William Bruss, Chief Executive Officer of Waterstone Financial, Inc.
Advasa Holdings, Inc. appointed Andre Thompson as an Independent Non-Executive Director to its Board of Directors, effective November 10, 2026. Mr. Thompson will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, acting as chairperson for the latter. He brings over 20 years of experience in real estate development and will receive standard independent director compensation.
Tonix Pharmaceuticals filed a patent infringement lawsuit against Dr. Reddy’s Laboratories in the U.S. District Court for the District of New Jersey following a Paragraph IV certification regarding TONMYA®. The filing of the complaint triggers a statutory 30-month stay of final FDA approval for Dr. Reddy’s proposed generic version of the drug. Tonix seeks to prevent generic competition until the expiration of its Orange Book-listed patents.
Affirm Holdings Insider Noel Bertram Watson Sells $134K of Stock
Noel Bertram Watson sold 2,000 shares of Affirm Holdings, Inc. at $66.90 a share, worth $134K in total on Nov 10, 2026. Shares held after the trade: 32,076 (-5.9%).
Actuate Therapeutics reported a net loss of $13.9 million for the nine months ended September 30, 2026, compared to $17.7 million in the prior year period. The company's cash position decreased significantly to $2.1 million, resulting in a working capital deficit and a stated going concern uncertainty as it continues to fund clinical development of elraglusib.
Amesite Inc. received a deficiency notice from Nasdaq on November 11, 2026, for failing to maintain the minimum $1.00 bid price requirement for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Management is monitoring the situation and may consider a reverse stock split if necessary to maintain its listing on The Nasdaq Capital Market.
First National Corporation entered into a new Supplemental Executive Retirement Plan (2026 SERP) with President and CEO Scott C. Harvard, providing a one-time lump sum retirement benefit of $2,376,298. The benefit is payable within 30 days of his separation from service for any reason other than cause. Additionally, the company amended Mr. Harvard's existing 2014 employment agreement to reflect the new SERP terms.
Stemtech Corp reported a significant decline in net sales to $1.37 million for the nine months ended September 30, 2026, compared to $2.42 million in the prior year period. The company continues to operate at a loss, with a net loss of $1.93 million for the first nine months of 2026 and a total stockholders' deficit of $8.38 million.
EXOZYMES INC. reported a net loss of $7.49 million for the nine months ended September 30, 2026, compared to a $6.50 million loss in the prior year. The company remains in a development stage with no operating income, primarily funded by a public offering and registered direct offering that raised approximately $5.86 million in net proceeds during the period.
BIO-key International reported total revenues of $5.5M for the nine months ended September 30, 2026, an increase from $4.9M in the prior year period, driven by higher license fees. Despite the revenue growth, the company incurred a net loss available to common stockholders of $6.2M, significantly impacted by a $4.5M deemed dividend related to a warrant inducement.
Santander Holdings USA, Inc. reported 530,391,043 shares of common stock outstanding as of October 31, 2026. The filing highlights significant strategic developments, including the acquisition of Webster and the subsequent merger of Webster Bank into SBNA, while noting risks related to inflation, interest rate volatility, and regulatory compliance.
Profusa, Inc. reported a net loss of $17.2 million for the nine months ended September 30, 2026, an improvement from the $31.2 million loss in the prior year period. The company's balance sheet was significantly impacted by the issuance of a $28.3 million G3 call option asset and the settlement of various liabilities through the issuance of Series A non-voting convertible preferred stock.
Amplify Commodity Trust reported a significant increase in combined net assets from $45.1 million at June 30, 2026, to $226.6 million at September 30, 2026, primarily driven by growth in the Breakwave Tanker Shipping ETF. The Tanker Shipping ETF saw its net asset value per share rise from $151.05 to $792.20 during the quarter, supported by $35.4 million in unrealized appreciation on futures contracts.
John Simard, Director, bought 70,000 shares of XBiotech Inc. at $2.05 a share, worth $143K in total on Nov 3, 2026. Shares held after the trade: 4,261,690 (+1.7%).
Our Bond, Inc. founder and CEO Doron Kempel hosted a live webinar on November 13, 2026. The company furnished a formal presentation deck as an exhibit to the filing for the event.
American Shared Hospital Services reported a net loss of $2,866,000 for the nine months ended September 30, 2026, compared to a loss of $1,719,000 in the prior year period. While total revenues increased to $23,138,000, higher operating costs and selling and administrative expenses led to an increased operating loss of $2,598,000.
For the nine months ended September 30, 2026, Utah Medical Products reported net sales of $25.87 million, a decrease from $29.48 million in the prior year period. Despite the decline in revenue, the company maintained profitability with a net income of $8.08 million and ended the period with a strong cash and investment balance of $85.20 million.
Green Planet Bio Engineering Co. Ltd. remains a shell company with no revenue and a net loss of $25,289 for the nine months ended September 30, 2026. The company's operations are funded through related party advances, resulting in a total stockholders' deficit of $526,265.
Benchmark 2026-V24 Mortgage Trust Capital Raise of $759M
Benchmark 2026-V24 Mortgage Trust completed the issuance and sale of Commercial Mortgage Pass-Through Certificates totaling approximately $759.3 million. The offering included $682.4 million in publicly offered certificates and $76.9 million in privately offered certificates sold to a group of underwriters and initial purchasers led by Goldman Sachs & Co. LLC.